← Leaderboards
Stephanie Teal
University Of Colorado Denver
$480,307
Attributed
$480,307
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $312.9K · FY2017–20$500K$375K$250K$125K$0
'17
'18
'19
'20
Funding mix
By agency
NIH$480,307 · 1
By mechanism
N01$480,307 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Colorado Denver
Same institution · by research overlap
- Kathryn B Horwitz$6,753,278
- Steven M Anderson$12,033,077
- David L Bain$4,362,761
- Steven K Nordeen$2,823,239
- Margaret C Neville$2,586,798
Others in their field
Other Emerging Leaders on “Regimen”
- Yunda Huang · Fred Hutchinson Cancer Center$53,780,853
- Gautam (george) Mitra · Leidos Biomedical Research, Inc.$53,523,213
- Paula Gonzalez-Maya · Fundacion Inciensa$38,145,031
- Beth Baseler · Leidos Biomedical Research, Inc.$24,452,367
- Olwen Hahn · Brigham And Women'S Hospital$23,582,395
- Julie Ake · National Institute Of Allergy And Infectious Diseases$17,792,120
Research focus
RegimenAdherenceProgestinsPublic HealthRandomizedAcetatesReproductiveSafetyUnited States Food And Drug AdministrationUterine FibroidsWomanAmenorrheaClinical TrialsClinical Trials NetworkContraceptive AgentsContraceptive EfficacyContraceptive MethodsDoseEmergency ContraceptionEstrogensHemorrhageInterruptionIn VitroMalignant Breast Neoplasm
Grant awards (2)
A MULTI-CENTER, RANDOMIZED STUDY TO EVALUATE THE PHARMACOKINETIC AND PHARMACODYNAMIC PROFILE, CONTRACEPTIVE EFFICACY AND SAFETY OF DAILY ORAL LOW DOSE ULIPRISTAL ACETATE$167,446
N01 · FY2020 · HD · contact PI
A MULTI-CENTER, RANDOMIZED STUDY TO EVALUATE THE PHARMACOKINETIC AND PHARMACODYNAMIC PROFILE, CONTRACEPTIVE EFFICACY AND SAFETY OF DAILY ORAL LOW DOSE ULIPRISTAL ACETATE$312,861
N01 · FY2017 · HD · contact PI